老年肾病综合征患者的抗凝治疗  

Anticoagulant therapy in elderly patients with nephrotic syndrome

作　　者：何娟 雍珍珠 赵卫红[2] He Juan;Yong Zhenzhu;Zhao Weihong(Department of Nephrology,the First Hospital of Xi'an,Xi'an 710000,China;Division of Nephrology,Department of Geriatrics,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China)

机构地区：[1]西安市第一医院肾脏内科,710000 [2]南京医科大学第一附属医院老年肾科,210029

出　　处：《中华老年医学杂志》2021年第10期1241-1244,共4页Chinese Journal of Geriatrics

基　　金：国家重点研发计划(2018YFC2002100、2018YFC2002102)江苏省医学重点学科(ZDXKA2016003)江苏省医学人才项目(ZDRCA2016021)江苏省干部保健课题(BJ17018)江苏省人民医院511工程(JSPH-511A-2018-5)。

摘　　要：肾病综合征(NS)患者血栓栓塞事件发生率高,老年人群血栓风险及出血风险均增加。本文结合2020年改善肾脏病预后全球组织(KDIGO)肾小球肾炎指南就老年NS人群血栓栓塞及出血风险评估、抗凝治疗和预防的时机以及药物选择等方面进行讨论。There is a high incidence of thromboembolic events in patients with nephrotic syndrome(NS),and the risk of thrombosis and bleeding increases in the elderly.On the basis of the guidelines of Kidney Disease:Improving Global Outcomes(KDIGO)glomerulonephritis 2020,the risk assessment of thromboembolism and bleeding,the timing of anticoagulant therapy and prevention and the selection of drugs for elderly NS individuals are discussed in this review.

关 键 词：肾病综合征 抗凝药 

分 类 号：R692[医药卫生—泌尿科学]